Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):108-115.

Více informací ZDE 

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.

Radiother Oncol. 2020 Jan;142:52-61.

Více informací ZDE 

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.

Radiother Oncol. 2020 Jan;142:62-71.

Více informací ZDE 

Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial.

Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):282-290.

Více informací ZDE 

Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome.

Radiother Oncol. 2020 Feb;143:24-29.

Více informací ZDE 

Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial.

J Clin Oncol. 2020 Feb 20;38(6):593-601.

Více informací ZDE 

Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial.

Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):706-714.

Více informací ZDE 

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.

Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):693-702.

Více informací ZDE 

Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.

Radiother Oncol. 2020 Mar;144:65-71.

Více informací ZDE 

Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.

Radiother Oncol. 2020 Mar;144:209-217.

Více informací ZDE 

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

J Clin Oncol. 2020 Mar 1;38(7):706-714.

Více informací ZDE 

Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.

Oncologist. 2020 Apr;25(4):e701-e708.

Více informací ZDE 

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

J Clin Oncol. 2020 Apr 1;38(10):1019-1029.

Více informací ZDE 

Imaging-based Target Volume Reduction in Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer (PET-Plan): A Multicentre, Open-Label, Randomised, Controlled Trial.

Lancet Oncol. 2020 Apr;21(4):581-592.

Více informací ZDE 

Late Toxicity and Quality of Life With Prostate Only or Whole Pelvic Radiation Therapy in High Risk Prostate Cancer (POP-RT): A Randomised Trial.

Radiother Oncol. 2020 Apr;145:71-80.

Více informací ZDE 

Randomized, Placebo-Controlled Clinical Trial Combining Pentoxifylline-Tocopherol and Clodronate in the Treatment of Radiation-Induced Plexopathy.

Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):154-162.

Více informací ZDE 

Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.

J Clin Oncol. 2020 May 20;38(15):1685-1692.

Více informací ZDE 

Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.

J Clin Oncol. 2020 May 20;38(15):1676-1684.

Více informací ZDE 

Quality of Life After Breast-Conserving Therapy and Adjuvant Radiotherapy for Non-Low-Risk Ductal Carcinoma in Situ (BIG 3-07/TROG 07.01): 2-year Results of a Randomised, Controlled, Phase 3 Trial.

Lancet Oncol. 2020 May;21(5):685-698.

Více informací ZDE 

Hypofractionated Breast Radiotherapy for 1 Week Versus 3 Weeks (FAST-Forward): 5-year Efficacy and Late Normal Tissue Effects Results From a Multicentre, Non-Inferiority, Randomised, Phase 3 Trial.

Lancet. 2020 May 23;395(10237):1613-1626.

Více informací ZDE 

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.

J Clin Oncol. 2020 Jun 1;38(16):1763-1773.

Více informací ZDE 

Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401) †.

Eur Urol. 2020 Jun;77(6):689-698.

Více informací ZDE 

Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).

Eur Urol. 2020 Jun;77(6):713-724.

Více informací ZDE 

Compliance and Tolerability of Short-Course Radiotherapy Followed by Preoperative Chemotherapy and Surgery for High-Risk Rectal Cancer - Results of the International Randomized RAPIDO-trial.

Radiother Oncol. 2020 Jun;147:75-83.

Více informací ZDE 

Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer.

Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):499-511.

Více informací ZDE 

No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial.

Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):701-709.

Více informací ZDE 

Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer.

Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):943-948.

Více informací ZDE 

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.

Radiother Oncol. 2020 Sep;150:18-25.

Více informací ZDE 

1